Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Educational interventions alone and combined with port protector reduce the rate of central venous catheter infection and colonization in respiratory semi-intensive care unit

BMC Infectious Diseases volume 19, Article number: 215 (2019) Cite this article

Abstract

Background

Central Line-Associated BloodStream Infections (CLABSIs) are emerging challenge in Respiratory semi-Intensive Care Units (RICUs). We evaluated efficacy of educational interventions on rate of CLABSIs and effects of port protector as adjuvant tool.

Methods

Study lasted 18 months (9 months of observation and 9 of intervention). We enrolled patients with central venous catheter (CVC): 1) placed during hospitalization in RICU; 2) already placed without signs of systemic inflammatory response syndrome (SIRS) within 48 h after the admission; 3) already placed without evidence of microbiologic contamination of blood cultures.

During interventional period we randomized patients into two groups: 1) educational intervention (Group 1) and 2) educational intervention plus port protector (Group 2).

We focused on CVC-related sepsis as primary outcome. Secondary outcomes were the rate of CVC colonization and CVC contamination.

Results

Eighty seven CVCs were included during observational period. CLABSIs rate was 8.4/1000 [10 sepsis (9 CLABSIs)]. We observed 17 CVC colonizations and 6 contaminations. Forty six CVCs were included during interventional period. CLABSIs rate was 1.4/1000. 21/46 CVCs were included into Group 2, in which no CLABSIs or contaminations were reported, while 2 CVC colonizations were found.

Conclusions

Our study clearly shows that both kinds of interventions significantly reduce the rate of CLABSIs. In particular, the use of port protector combined to educational interventions gave zero CLABSIs rate.

Trial registration

NCT03486093 [ClinicalTrials.gov Identifier], retrospectively registered.

Peer Review reports

Background

Central Line-Associated BloodStream Infections (CLABSIs) are responsible for as many as 28,000 deaths in the United States annually [1,2,3,4,5,6,7]. A recent analysis found that 65–70% of CLABSIs could be prevented with the proper institution of catheter care measures [8].

There are 2 main routes by which central venous catheters (CVCs) become colonized: from bacteria contaminating the outside of the catheter either at the time of insertion or after insertion (extraluminal) and/or by contamination of the hub, catheter, or other administration device (intraluminal). The extraluminal pathway predominates in the first week after CVC placement, whereas the intraluminal mechanism is the more common pathway for CVCs that are > 1 week old [9, 10].

Several collaboratives have demonstrated the preventability of these infections [11, 12]. Educational interventions decrease rates of CLABSIs [13]. In addition to training, education, and surveillance, important prevention practices include the use of chlorhexidine skin antiseptics and maximal sterile barrier precautions at catheter insertion [14, 15].

Other maintenance practices include hand hygiene before handling catheters or catheter sites, chlorhexidine for skin antisepsis with dressing changes, and disinfecting catheter hubs or injection ports with an appropriate agent before accessing the catheter [16, 17].

Non antibiotic antiseptic locks (such as alcohol or trisodium citrate), have also demonstrated some success in reducing CLABSIs. In particular, alcohol-impregnated port protectors and needleless neutral pressure connectors significantly reduced rates of CLABSIs [18].

To date, in literature, no data exist on rate, risk factors and prevention strategies of CLABSIs in RICUs. These units usually work as “step-up” units within acute care hospitals to manage patients with respiratory failure with non-invasive ventilation [19, 20]. These units may provide multidisciplinary rehabilitation [21] and serve as a bridge to home-care programs or long-term care facilities [22]. Some of these RICUs may work also as “step down” units for difficult to wean patients [23].

We performed a single-centre prospective study with the aim to assess the efficacy of educational interventions alone and combined with port protector as adjuvant tool on rate of CLABSIs (primary outcome). Secondary outcomes were the effects of previously mentioned interventions on rates of CVC colonizations and contaminated blood cultures.

Methods

This study was approved by the Local Ethical Committee of the Catholic University of the Sacred Heart in Rome, Italy (Prot.n°5664) and it was performed according to the Helsinki Declaration of Good Clinical Practice. Three departments were involved: Respiratory semi-Intensive Care Unit, Institute of Microbiology and Institute of Infectious Diseases.

Participants

The study enrolled patients admitted to RICU from April 2013 and it lasted 18 months. We chose three mutually exclusive inclusion criteria were: 1) CVC was placed during hospitalization in RICU; 2) CVC already in place at admittance without signs of systemic inflammatory response syndrome (SIRS) during first 48 h from admission to RICU [24]; 3) CVC already placed at admittance without evidence of microbiologic contamination of blood cultures.

Each patient gave written informed consent.

Patients enrolled underwent blood cultures sampling whenever they showed SIRS signs.

SIRS is defined as 2 or more of the following variables: 1) fever of more than 38 °C (100.4 °F) or less than 36 °C (96.8 °F), 2) heart rate of more than 90 beats per minute, 3) respiratory rate of more than 20 breaths per minute or arterial carbon dioxide tension (PaCO2) of less than 32 mmHg, 4) abnormal white blood cell count (> 12,000/μL or < 4000/μL or > 10% immature [band] forms) [24, 25]. Septic shock was defined as sepsis associated with organ dysfunction and persistent hypotension despite volume replacement [24, 25].

According to international guidelines [26,27,28], blood cultures were collected simultaneously from both central line and peripheral blood.

So doing, we identified five different mutually exclusive conditions: 1) significant different time to positivization of blood cultures (at least 2 h) between central line sample and peripheral sample (sepsis related to CVC – CLABSIs); 2) not significant different time to positivization of blood cultures (sepsis not related to CVC); 3) positive blood cultures from central line sample and negative from peripheral one (CVC colonization); 4) negative blood cultures from central line sample and positive from peripheral one (contaminated blood cultures); 5) negative blood cultures from both peripheral and central line samples (SIRS not sustained by sepsis). CVCs were removed when conditions 1 and 3 occurred. Catheter tips were collected and prepared for subsequent microbiological analysis and identified microbial species have been reported.

Each catheter was designated by type of vessel used (peripheral versus central); site of insertion (subclavian, femoral, internal jugular, peripheral, and Peripherally Inserted Central Catheter [PICC]) [10, 16].

Moreover, for each patient, data concerning provenance, parenteral nutrition, presence of tracheostomy tube and mechanical ventilation were collected.

Finally, in order to measure the severity of clinical condition of each patient, we adopted APACHE III score [29] and Charlson’s Comorbidity Index score [30].

Microbiological methods

The entire medical center is served by a central microbiology laboratory, which is open from 7:00 AM to 7:00 PM, Monday through Saturday.

For adult patients with suspected BSIs, the center’s standard of care requires the sequential collection at 30-min intervals of at least three sets of aerobic and anaerobic BCs (CLSI). For each set, a 20-mL blood sample is collected via a single venipuncture or intravascular line access. Skin or access ports are disinfected with alcohol and povidone iodine.

The blood sample is used to inoculate one BACTEC Plus Aerobic/F and Anaerobic bottles (10 mL of blood each) (Becton Dickinson Instrument Systems, Sparks, Md). The bottles are brought to the laboratory and incubated up to 5 days in the BACTEC FX automated blood culture instrument (Cultures arriving when the laboratory is closed are stored at room temperature in accordance with manufacturers’ instructions). When the growth index of a bottle was positive, broth aliquots were collected for standard identification studies, which entailed Gram staining (the results of which were immediately reported to the patient’s physician), routine subculture, and matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry (MALDI BioTyper, Bruker Daltonik GmbH, Leipzig, Germany) analysis of culture samples, supplemented when necessary with additional biochemical methods and/or 16S rRNA gene sequencing [31, 32]. Antibiotic susceptibility tests were performed using the Vitek 2 system (bioMérieux, Marcy l’Etoile, France). Confirmatory MIC testing for oxyimino-cephalosporins and carbapenems was carried out by Etest (bioMérieux). Results were interpreted according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints (EUCAST table). Catheter tip cultures were performed according to the method described by Maki et al. [33].

Study design

The study was divided in two periods of equal duration time (9 months): a preliminary prospective observational period (phase I) and a subsequent prospective interventional period (phase II).

Patients enrolled during phase I were the Treat 0 group. During phase II, two interventional strategies have been adopted:

  1. 1.

    at the beginning of interventional study and then every 45 days, physicians and nurses of RICU have been trained and retrained to GAVECELT (“Long Term Venous Central Lines” Open Group – https://gavecelt.it/nuovo/) “bundle” recommendations concerning the management of CVC. The bundle includes: hand hygiene and precautions for protection and safety, adequate insertion site, echo-guided placement of central venous line, use of clorexidine 2% for skin disinfection of insertion site chosen and subsequent continuous or discontinuous disinfection of exit site, use of suture-less devices, use of transparent semi-permeable dressing whenever applicable and immediate removal of catheter when no longer needed. Moreover, in order to reduce the use of unnecessary catheters, we regularly evaluated the need for CVCs for both patients admitted to RICU and patients moved out of the ICU and unnecessary catheters were promptly removed.

  2. 2.

    After the first training meeting, the use of Curos® Disinfecting Port Protector for needleless valves port-protector (CUROS, 70% isopropyl alcohol-impregnated, Ivera Medical, San Diego, California, US) has been introduced.

Patients ruled in during the interventional period have been randomized into two groups:

  1. 1.

    patients with CVC managed by healthcare workers trained/retrained to GAVECELT recommendations (Treat 1 group).

  2. 2.

    Patients with CVC managed by healthcare workers trained/retrained to GAVECELT recommendations with the aid of port protector devices (Treat 2 group).

Curos® Disinfecting Port Protector is a passive disinfection device that luer-locks securely onto needleless IV ports to disinfect in 3 min. If not removed, ports stay clean and protected for 7 days. The Curos® is intended for use on swabbable luer access valves as a disinfecting cleaner prior to line access and to act as a physical barrier to contamination between line accesses. Curos disinfects the valve three minutes after application and acts as a physical barrier to contamination for up to seven days if not removed.

Analysis

Description of the sample was made calculating mean values and standard deviation for continuous variables, percentages for dichotomous or ordinal variables.

Simple randomization was the method used (Stata version 9, StataCorp LLC, USA).

Regarding concealment, a centralized computer algorithm was adopted to assign subjects to Treat 1 or Treat 2 group.

The head of nurses (MC) and physicians allocated to the intervention groups (GP, DM, GM) were aware of the allocated arm, outcome assessors and data analysts (RI, GS, GMC, RT, TS) were kept blinded to the allocation.

Overall catheter dwell time was reported. CLABSIs rate expressed as number of sepsis related to CVC per 1000 days of catheter dwell time was computed. Data concerning number of CVC colonizations, contaminated blood cultures and negative blood cultures have been also reported.

The primary analysis was a quasi-experimental design comparing baseline rate of outcome measurements (the rates of CLABSIs, CVC colonizations and contaminated blood cultures) to the rates during the intervention. Then, the same measurements were compared between the two interventional groups (educational alone and combined with port protector).

Incidence of primary and secondary outcomes were analyzed using log rank test and Cox regression.

Variables included in the model were: type of treatment (educational interventions and educational interventions + Curos compared to the observational period), site of insertion, APACHE III score, Charlson Comorbidity Index, provenance of patient, hospital days before the admission to RICU, presence of tracheostomy, length of stay on mechanical ventilation, age and sex.

Results

One hundred thirty-two patients were enrolled: 86 during the observational period (phase I) and 46 during interventional period (phase II), the latter divided randomly into two study groups: 25 in study group of educational interventions (Treat 1 group) and 21 in study group of educational interventions + Curos (Treat 2 group) (see Consort 2010 Flow Diagram).

Table 1 shows demographic characteristics of study population divided into three study groups. The three study groups did not differ in severity of clinical condition, assessed by APACHE III score and Charlson Comorbidity index, percentage of patients on mechanical ventilation, also through tracheostomy. Instead, there is a higher percentage of patients on parenteral nutrition in study group 0. The central venous accesss were divided in PICC, venous access placed in the subclavian vein / internal jugular vein and venous access placed in the femoral vein. Table 1 describes the distribution of type of venous catheter in the three study groups considered.

Table 1 Demographic characteristics of the study population.
Full size table

Table 2 describes rate of CLABSIs, colonizations of CVCs and contaminated blood cultures during observational period (phase I) and interventional period (phase II).

Table 2 The rate of CLABSIs, CVC colonizations and contaminations of blood cultures.
Full size table

During the first period, rate of CLABSIs (expressed as CLABSIs / 1000 catheter days of life) was 8.6.

The measures implemented during interventional period led to a reduction of rate of both CLABSIs and colonizations of venous catheters.

In particular, educational measures combined to device led to zero the cases of CLABSIs. The comparison between two periods has detected a reduction of incidence of CLABSIs at the margin of significance [log rank test, p = 0.0568]. Moreover, risk of CLABSIs reduced during interventional period, with the hazard ratio (HR) of 0.17 [95% Conf. Interval: 0.02–1.36, p = 0.096] [Cox regression – Breslow method] [Fig. 1].

Fig. 1
figure 1

Kaplan-Meier curves: estimates of occurrence of CLABSIs by treatment: interventional period (Treat 1 group) compared with observational period (Treat 0 group)

Full size image

Subsequently, we focused on patients with colonization of venous catheter.

First, we performed univariate analysis (log-renk test) to evaluate incidence and, subsequently, risk of colonization according to treatment, excluding cases of CLABSI and comparing patients with CVC colonization with ones with contamination of blood cultures and negativity of microbiological investigations (negative).

During prospective interventional period, implemented treatments led to a reduction of incidence of colonization [log rank test, p = 0.0635]. Moreover, risk of colonization reduced in both treatment groups during interventional period, with HR of 0.30 [95% Conf. Interval: 0.07–1.29] for Treat 1 group (educational interventions) and HR of 0.33 [95% Conf. Interval: 0.07–1.45] for Treat 2 group (educational interventions + Curos) [Cox regression – Breslow method] [Fig. 2].

Fig. 2
figure 2

Kaplan-Meier curves: estimates of occurrence of CVC colonization by treatment: interventional period (Treat 1 group and Treat 2 group) compared with observational period (Treat 0 group)

Full size image

Subsequently, we evaluated the distribution of cases of CVC colonization according to site of insertion and the risk of colonization of CVC with Cox regression – Breslow method analysis [Table 3].

Table 3 CVC colonizations according to the site of insertion.
Full size table

It is possible to observe that risk of colonization of CVC significantly reduced in both interventional groups (HR: 0.07, 95% Conf. Interval: 0.01–0.51 for Treat 1 group – educational interventions; HR: 0.14, 95% Conf. Interval: 0.02–0.83 for Treat 2 group – educational interventions + Curos). Conversely, there was a significantly increased risk of colonization of CVC for patients to whom venous catheter was placed in subclavian / internal jugular vein and femoral vein with HR of 6.14 and 8.17, respectively.

Finally, we observed that use of educational measures combined to application of device led to zero cases of contaminated blood cultures [Table 2]. Nonetheless, there was no significant reduction between two study periods [log rank test, p = 0.6139] [Fig. 3].

Fig. 3
figure 3

Kaplan-Meier curves: estimates of occurrence of CVC contamination by treatment: interventional period (Treat 1 group) compared with observational period (Treat 0 group)

Full size image

The organisms recovered are presented in Table 4.

Table 4 Distribution of CLABSI organisms, CVC colonization organisms and contaminated blood culture organisms.
Full size table

Discussion

In this prospective randomized study, we explored rate of CLABSIs, CVC colonizations and contaminated blood cultures before and after introduction of educational interventions alone and combined with port protector as adjuvant tool.

To the best of our knowledge, this is the first study performed in a RICU.

Three main conclusions can be extracted from this work. (i) educational interventions combined to Curos® Disinfecting Port Protector led to zero rate of CLABSIs. Additionally, risk of CLABSIs reduced during interventional period. (ii) The measures implemented reduced also rate of colonizations of the venous catheters. Lastly, (iii) risk of colonization of CVC increased for patients to whom venous catheter was placed in subclavian / internal jugular vein and femoral vein.

The importance of the education of healthcare personnel regarding the indications for intravascular catheter use, proper procedures for the insertion and maintenance of intravascular catheters, and appropriate infection control measures to prevent intravascular catheter-related infections is well known [34]. Furthermore, previous studies also highlighted the need of periodical assessment of knowledge of and adherence to guidelines for all personnel involved in insertion and maintenance of intravascular catheters [34, 35].

Recently, Sweet MA et al. [18] showed that alcohol-impregnated port protectors and needleless neutral pressure connectors significantly reduced rates of CLABSIs and contaminated blood cultures in an oncology patient population. Similar results were reported by Wright MO et al., [36] where disinfection cap with 70% alcohol reduced line contamination, organism density, and CLABSIs.

The novelty of our study consists in performing a prospective study with the specific aim of assessing effects of educational interventions combined to alcohol-impregnated port protector on rate and risk of CLABSIs, CVC colonizations and contaminated blood cultures in a clinical setting at high risk of bloodstream infections.

This strategy allowed us to zero rate of CLABSIs (from 8.6 CLABSIs / 1000 catheter days of life to 2.6 with educational interventions and zero with educational interventions combined to port protector). Our experience demonstrates that this goal, warmely supported by international experts [10], is feasible.

Another interesting observation is that this preventive strategy reduced also risk of CLABSIs (83% reduction).

Strong evidence exists in literature about reduction of risk for infection following standardization of aseptic care [34, 35]. Moreover, specialized “IV teams” reduced incidence of catheter-related bloodstream infections, associated complications, and costs [37].

In our hospital, there is a specialized IV team dedicated to the CVC placement. Therefore, we preferred to focus our attention on management of catheter essentialy based on training and retraining of physicians and nurses of the RICU to GAVECELT “bundle” recommendations.

The reduction of both rate and risk of CLABSIs confirms previous reports [9, 38] asserting the catheter hub colonization as the primary pathogenetic explanation of central catheter infections after the insertion (intraluminal causal pathway).

In our study, both treatments caused a decrease of rate of CVC colonizations (70% reduction with educational interventions and 67% reduction with educational interventions combined to port protector).

This is in line with the observations by Wright MO, who found that the catheter hub contamination was significantly less likely to occur, and, when it did occur, the number of recovered organisms were significantly fewer with the use of the disinfection cap [36].

Subsequently, we observed that risk of colonization of CVC significantly reduced in both interventional groups (93% reduction with educational interventions and 86% reduction with educational interventions and Curos). Conversely, there was a significantly increased risk of colonization of CVC for patients to whom venous catheter was placed in subclavian / internal jugular vein (HR of 6.14) and femoral vein (HR of 8.17) compared to patients to whom a PICC was placed.

Our study confirms that site at which a catheter is placed influences the subsequent risk for catheter-related infection. The influence of site on the risk for catheter infections is related in part to the density of local skin flora.

As far as we know, this is the first study that prospectively compared infection rates for catheters placed in jugular, subclavian, femoral and peripheral veins (PICC). In agreement with literature [39], our results highlight that femoral catheters have highest colonization rates.

Finally, we observed that educational measures combined to port protector led to zero the cases of contaminated blood cultures.

This study has some limitations. First, sample size is apparently limited if compared to study period (18 months). Our RICU works essentially as “step down” unit for difficult to wean patients coming from our ICUs (more than 50% of enrolled patients). Moreover, our unit provides multidisciplinary rehabilitation and serves as a bridge to home-care programs or long-term care facilities. Mean length of stay in our unit was 33 days and this partially explains the number of enrolled patients.

Furthermore, number of patients enrolled during interventional period was lower than that of the observational period. We believe that this apparent limitation reflects a better selection of patients who will benefit from the use of catheters due to educational training/retraining, thus this finding can be considered a positive result of the study.

Conclusions

This study shows that synergistic effects of educational interventions and use of Curos® Disinfecting Port Protector allow to zero rate and reduce the risk of CLABSIs in a Respiratory semi-Intensive Care Unit.

Abbreviations

CLABSIs:

Central Line-Associated BloodStream Infections

CRBSIs:

Catheter-related BSIs

CVC:

Venous central catheter

EUCAST:

European Committee on Antimicrobial Susceptibility Testing

HR:

Hazard ratio

ICU:

Intensive Care Unit

PICC:

peripherally inserted central catheter

RICU:

Respiratory semi-Intensive Care Unit

SIRS:

Systemic inflammatory response syndrome

References

  1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–17.

    Article  Google Scholar 

  2. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 2000;21:510–5.

    Article  CAS  Google Scholar 

  3. Lyytikäinen O, Lumio J, Sarkkinen H, Kolho E, Kostiala A, Ruutu P, Hospital Infection Surveillance Team. Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. Clin Infect Dis. 2002;35:e14–9.

    Article  Google Scholar 

  4. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122:160–6.

    Article  Google Scholar 

  5. Vandijck DM, Depaemelaere M, Labeau SO, et al. Daily cost of antimicrobial therapy in patients with intensive care unit-acquired, laboratory-confirmed bloodstream infection. Int J Antimicrob Agents. 2008;31:161–5.

    Article  CAS  Google Scholar 

  6. Blot SI, Depuydt P, Annemans L, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005;41:1591–8.

    Article  Google Scholar 

  7. Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med. 2006;34:2084–9.

    Article  Google Scholar 

  8. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32:101–14.

    Article  Google Scholar 

  9. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993;168:400–7.

    Article  CAS  Google Scholar 

  10. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S. Healthcare Infection Control Practices Advisory Committee Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39:S1–34.

    Article  Google Scholar 

  11. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725–32 Erratum in: N Engl J Med 2007; 356: 2660.

    Article  CAS  Google Scholar 

  12. Warren DK, Cosgrove SE, Diekema DJ, et al. Prevention epicenter program. A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol. 2006;27:662–9.

    Article  Google Scholar 

  13. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339–43.

    Article  CAS  Google Scholar 

  14. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15:231–8.

    Article  CAS  Google Scholar 

  15. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med. 2004;32:2014–20.

    Article  Google Scholar 

  16. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep. 2002;51(RR-10):1–29.

    Google Scholar 

  17. Centers for Disease Control and Prevention. Reduction in central line associated bloodstream infections among patients in intensive care units—Pennsylvania, April 2001–March 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1013–6.

    Google Scholar 

  18. Sweet MA, Cumpston A, Briggs F, Craig M, Hamadani M. Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit. Am J Infect Control. 2012;40:931–4.

    Article  Google Scholar 

  19. Ambrosino N, Vagheggini G. Noninvasive positive pressure ventilation in the acute care setting: where are we? Eur Respir J. 2008;31:874e86.

    Article  Google Scholar 

  20. Nava S, Hill N. Non-invasive ventilation in acute respiratory failure. Lancet. 2009;374:250e9.

    Article  Google Scholar 

  21. Thomsen GE, Snow GL, Rodriguez LAS, Hopkins RO. Patients with respiratory failure increase ambulation after transfer to an intensive care unit where early activity is a priority. Crit Care Med. 2008;36:1119e24.

    Article  Google Scholar 

  22. Corrado A, Roussos C, Ambrosino N, et al. European Respiratory Society task force on epidemiology of respiratory intermediate care in Europe. Respiratory intermediate care units: a European survey. Eur Respir J. 2002;20:1343–50.

    Article  CAS  Google Scholar 

  23. Confalonieri M, Gorini M, Ambrosino N, Mollica C, Corrado A. Scientific group on respiratory intensive Care of the Italian Association of hospital Pneumonologists. Respiratory intensive care units in Italy: a national census and prospective cohort study. Thorax. 2001;56:373e8.

    Article  Google Scholar 

  24. Bone RC, Balk RA, Cerra FB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–55.

    Article  CAS  Google Scholar 

  25. Russell JA. Management of sepsis. N Engl J Med. 2006;355:1699–713.

    Article  CAS  Google Scholar 

  26. CDC/NHSN Surveillance Definitions for Specific Types of Infections. Available at: http://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf.

  27. Clinical and Laboratory Standards Institute (CLSI). Principles and Procedures for Blood Cultures; Approved Guideline. CLSI document M47-A (ISBN 1–56238–641-7). 940 West Valley Road, Suite 1400, Wayne, Pennsylvania, USA: Clinical and Laboratory Standards Institute; 2007.

    Google Scholar 

  28. Baron EJ, Weinstein MP, Dunne WM Jr, Yagupsky P, Welch DF, Wilson DM. Blood Cultures IV. Washington, DC: ASM Press; 2005.

    Google Scholar 

  29. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619–36.

    Article  CAS  Google Scholar 

  30. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.

    Article  CAS  Google Scholar 

  31. Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, editors. Manual of clinical microbiology. 10th ed. Washington, DC: ASM Press; 2011.

    Google Scholar 

  32. Drancourt M, Berger P, Raoult D. Systematic 16S rRNA gene sequencing of atypical clinical isolates identified 27 new bacterial species associated with humans. J Clin Microbiol. 2004;42:2197–202.

    Article  CAS  Google Scholar 

  33. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977;296:1305–9.

    Article  CAS  Google Scholar 

  34. Warren DK, Cosgrove SE, Diekema DJ, et al. A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol. 2006;27:662–9.

    Article  Google Scholar 

  35. Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians in-training can decrease the risk for vascular catheter infection. Ann Intern Med. 2000;132:641–8.

    Article  CAS  Google Scholar 

  36. Wright MO, Tropp J, Schora DM, et al. Continuous passive disinfection of catheter hubs prevents contamination and bloodstream infection. Am J Infect Control. 2013;41:33–8.

    Article  Google Scholar 

  37. Hunter MR. Development of a vascular access Team in an acute care setting. J Infus Nurs. 2003;26:86–91.

    Article  Google Scholar 

  38. Dobbins BM, Kite P, Kindon A, McMahon MJ, Wilcox MH. DNA fingerprinting analysis of coagulase negative staphylococci implicated in catheter related bloodstream infections. J Clin Pathol. 2002;55:824–48.

    Article  CAS  Google Scholar 

  39. Lorente L, Jimenez A, Iribarren JL, Jimenez JJ, Martin MM, Mora ML. The micro-organism responsible for central venous catheter related bloodstream infection depends on catheter site. Intensive Care Med. 2006;32:1449–50.

    Article  Google Scholar 

Download references

Acknowledgements

The authors are grateful to all nurses of Respiratory semi-Intensive Care Unit of Fondazione Policlinico Universitario A. Gemelli in Rome for daily technical and material support.

Funding

No specific funding.

Availability of data and materials

The datasets used and analysed during the current study are available from the corresponding author on reasonable request.

Author information

Authors and Affiliations

  1. UOC Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

    Riccardo Inchingolo, Giuliana Pasciuto, Daniele Magnini, Manuela Cavalletti, Giuliano Montemurro, Andrea Smargiassi, Giuseppe Maria Corbo & Luca Richeldi

  2. UOC Malattie Infettive, Fondazione Polcilinico Universitario A. Gemelli IRCCS, Rome, Italy

    Giancarlo Scoppettuolo

  3. UOC Microbiologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

    Riccardo Torelli, Maurizio Sanguinetti & Teresa Spanu

  4. Istituto di Microbiologia, Università Cattolica del Sacro Cuore, Rome, Italy

    Maurizio Sanguinetti & Teresa Spanu

  5. UOC Pneumologia, Università Cattolica del Sacro Cuore, Rome, Italy

    Giuseppe Maria Corbo & Luca Richeldi

Authors
  1. Riccardo Inchingolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuliana Pasciuto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniele Magnini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Manuela Cavalletti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giancarlo Scoppettuolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giuliano Montemurro
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andrea Smargiassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Riccardo Torelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Maurizio Sanguinetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Teresa Spanu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Giuseppe Maria Corbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Luca Richeldi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RI, GS and GMC gave substantial contributions to conception and design and analysis and interpretation of data. Moreover, these authors were involved in drafting the manuscript. GP, DM, GM, AS, MC and RT gave substantial contributions to analysis and interpretation of data. MS, TS and LR revised the manuscript critically for important intellectual content and gave final approval of the version to be submitted. Each author have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Riccardo Inchingolo.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the local Ethical Committee of the Catholic University of the Sacred Heart in Rome, Italy (Prot.n°5664). The informed consent to participate was obtained from all participants in written form.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional information

This work has been accepted as oral communication at 3rd World Congress on Vascular Access held in Berlin, Germany, June 18-20, 2014 and as thematic poster at European Respiratory Society International Congress - Munich 2014.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inchingolo, R., Pasciuto, G., Magnini, D. et al. Educational interventions alone and combined with port protector reduce the rate of central venous catheter infection and colonization in respiratory semi-intensive care unit. BMC Infect Dis 19, 215 (2019). https://0-doi-org.brum.beds.ac.uk/10.1186/s12879-019-3848-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12879-019-3848-z

Keywords

BMC Infectious Diseases

ISSN: 1471-2334

Contact us